NSB Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,164
Closed -$303K 8
2015
Q1
$303K Hold
4,164
0.38% 21
2014
Q4
$287K Sell
4,164
-230
-5% -$15.5K 0.29% 20
2014
Q3
$285K Hold
4,394
0.24% 21
2014
Q2
$273K Hold
4,394
0.19% 22
2014
Q1
$259K Hold
4,394
0.17% 24
2013
Q4
$224K Hold
4,394
0.13% 27
2013
Q3
$221K Hold
4,394
0.13% 24
2013
Q2
$216K Buy
+4,394
New +$239K 0.12% 26

Other funds holding LLY

NSB Advisors's LLY Position: Q2 2015 in Review

NSB Advisors sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 4,164 shares — an estimated $303K sold.

NSB Advisors first reported a position in LLY in Q2 2013 and held it in 8 quarters. The position peaked at $303K in Q1 2015. 1,138 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

  • NSB Advisors reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
  • NSB Advisors sold 4,164 Eli Lilly shares in Q2 2015, an estimated $303K.
  • NSB Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 8 quarters.
  • NSB Advisors's Eli Lilly position peaked at $303K in Q1 2015.
  • 1,138 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on NSB Advisors's 13F filing for Q2 2015.